• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Jun 26;21(1):612.
doi: 10.1186/s12879-021-06294-2.
Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic


Alexander Kusnik[SUP] 1 2 [/SUP], Christel Weiss[SUP] 3 [/SUP], Melanie Neubauer[SUP] 1 [/SUP], Bianca Huber[SUP] 1 [/SUP], Marlis Gerigk[SUP] 4 [/SUP], Thomas Miethke[SUP] 4 5 [/SUP], Nicole Hunter[SUP] 4 [/SUP], Nicole Rotter[SUP] 6 [/SUP], Sonja Ludwig[SUP] 6 [/SUP], Angela Schell[SUP] 6 [/SUP], Matthias P Ebert[SUP] 1 2 [/SUP], Andreas Teufel[SUP] 7 8 9 [/SUP]



Affiliations

Abstract

Background: The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis and disruption of chains of infections.
Methods: Handing out detailed questionnaires to all individuals tested for COVID-19, we evaluated the clinical characteristics of negative and positive tested individuals. Expression of symptoms, symptom duration and association between predictor variables (i.e. age, gender) and a binary outcome (olfactory and gustatory dysfunction) were assessed.
Results: Overall, the most common symptoms among individuals who tested positive for SARS-CoV-2 were fatigue, headache, and cough. Olfactory and gustatory dysfunction were also reported by many SARS-CoV-2 negative individuals, more than 20% of SARS-CoV-2 negative tested individuals in our study reported olfactory and gustatory dysfunction. Independent of SARS-CoV-2 status, more females displayed symptoms of gustatory (29.8%, p = 0.0041) and olfactory dysfunction (22.9%, p = 0.0174) compared to men.
Conclusions: Bringing early SARS-CoV-2 tests to the populations at risk must be a main focus for the upcoming months. The reliability of olfactory and gustatory dysfunction in COVID-19 negative tested individuals requires deeper investigation in the future.

Keywords: Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste.
 
Back
Top Bottom